Form 8-K - Current report:
SEC Accession No. 0001641172-25-013823
Filing Date
2025-06-05
Accepted
2025-06-05 16:31:22
Documents
14
Period of Report
2025-06-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 43234
2 EX-16.1 ex16-1.htm EX-16.1 2365
  Complete submission text file 0001641172-25-013823.txt   260054

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE drma-20250603.xsd EX-101.SCH 3780
4 XBRL DEFINITION FILE drma-20250603_def.xml EX-101.DEF 26634
5 XBRL LABEL FILE drma-20250603_lab.xml EX-101.LAB 37701
6 XBRL PRESENTATION FILE drma-20250603_pre.xml EX-101.PRE 25258
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5882
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 251027559
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)